Monsenso is Cyber Essentials certified

Monsenso is Cyber Essentials certified

Copenhagen, Denmark – 8th of April 2021.

Monsenso A/S, a technology leader in digital health solutions for mental health is now Cyber Essentials certified.
The Monsenso digital health solution that connects individuals and clinicians to provide optimal care received a Cyber Essentials certification demonstrating the company’s commitment to security and data protection.

Cyber Essentials is the UK Government’s answer to a safer internet space for organisations of all sizes, across all sectors. Developed and operated by the National Cyber Security Centre (NCSC), the Cyber Essentials certificate assures that essential cyber security measures are in place to protect data against cyber-attacks.

“Monsenso is committed to adhere to the highest security standards. Beyond the Cyber Essentials certification, Monsenso holds the ISO 13485 and ISO 27001 certifications, a TGA certification, class 1 CE mark and is HIPAA compliant. The Cyber Essentials certification demonstrates our continuous commitment to keep the data of our customers secure” says Thomas Lethenborg, CEO at Monsenso.

To read more about our data protection, download our Data management & Security fact sheet.

About Monsenso
Monsenso is an innovative technology company offering a digital health solution used for decentralised trials, remote patient monitoring and treatment support. Our mission is to contribute to improved health for more people at lower costs by supporting treatment digitally and leveraging patient-reported outcomes data. Our solution helps optimise the treatment and gives a detailed overview of an individual’s health through the collection of outcome, adherence, and behavioural data. It connects individuals, carers, and health care providers to enable personalised treatment, remote care, and early intervention. We collaborate with health and social care, pharmaceuticals, and leading researcher worldwide in our  endeavours to deliver solutions that fit into the life of patients and health care professionals. To learn more visit  www.monsenso.com.

For additional information contact:
Bettina van Wylich-Muxoll
Chief Marketing Officer
Monsenso
+45 22 70 47 24
marketing@monsenso.com

Monsenso expands in the Middle East with new million deal with global pharmaceutical company

Monsenso expands in the Middle East with new million deal with global pharmaceutical company

Monsenso has entered a new million agreement with a global pharmaceutical company and hereby expands its activities to six countries in the Middle East. As part of the agreement, Monsenso will provide its solution for patient monitoring and treatment support in the United Arab Emirates, Saudi Arabia, Oman, Kuwait, Qatar and Bahrain.

Monsenso’s solution will be used to support the treatment of depression and schizophrenia. Patients are provided with an app, which is used to collect real-time patient-reported information and to give patients access to information about their disorder between consultations. Therapists gain access to a clinical web portal and can follow their patients remotely and gain valuable information about behavior, medication intake and symptoms and thus be able to provide a data-driven treatment and allow for proactive follow-up.
In addition, the solution supports communication between patients and therapists.

“We are very pleased with this agreement, which contributes to both expanding our geographic market coverage and our business with pharmaceutical companies in line with our growth strategy. ” says Thomas Lethenborg, CEO of Monsenso. “Depression and schizophrenia are among the most costly disorders for society and have major consequences for affected patients and relatives. Therefore, we are proud to be able to contribute to better treatment within these disease areas.”

The project will not affect Monsenso’s previously communicated plans and guidance for the 2020 financial year.

To read the Danish version, click here.

For additional information contact:
Bettina van Wylich-Muxoll
Chief Marketing Officer
marketing@monsenso.com
Monsenso

Monsenso is expanding in the UK with a new Sales Office and hiring of Area Sales Manager

Monsenso is expanding in the UK with a new Sales Office and hiring of Area Sales Manager

Monsenso A/S is establishing an office in the UK to support the growth plan and is hiring Michelle Woolley as Area Sales Manager.

Monsenso, a technology leader in mobile health (mHealth) solutions for mental health is opening an office in London; Monsenso UK Ltd. to strengthen and support the expansion of the business in the UK, the company has hired Michelle Woolley as Area Sales Manager.

Michelle comes to Monsenso with a strong experience in sales management and business development from both Medtech and the pharmaceutical industry from i.e. Pfizer, 3M Healthcare, Servier, and Icentia

Michelle has a Microbiology degree BSc (Hons) from University of Bristol.

Michelle Woolley starts November 9, 2020.

With the opening of an office in the UK and the hiring of Michelle, we continue Monsenso’s international expansion in line with our growth strategy. Michelle will be an important addition to the team and we look forward to welcoming her”, says CEO Thomas Lethenborg.

Click on the link to read the press release in Danish.

For additional information, please contact:

Bettina van Wylich-Muxoll
Marketing
Monsenso
+45 22 70 47 24
marketing@monsenso.com

Six Aims of High Quality Healthcare (Infographic)

Six Aims of High Quality Healthcare (Infographic)

In 1998, the Quality Chasm series was launched by the Institute of Medicine which included an informative report about delivering high quality healthcare. The report was entitled  “Crossing the Quality Chasm: A New Health System for the 21st Century”.The strategies proposed in this report were to be used as an organizational model for a patient centered healthcare system, and to provide informative guidelines on how a healthcare delivery system can be redesigned to innovate and improve care. 

This informative report uses six primary aims to achieve and implement  high quality healthcare systems. Mobile Health solutions, such as our mHealth solution,  can meet all of those six aims.  See how below: 

An infographic of how the monsenso solution does meet the six aims of high quality digital healthcare